Remus Pharmaceuticals Ltd
company logo

Remus Pharmaceuticals Ltd

Pharmaceuticals
Small Cap

-

- (0%)


Remus Pharmaceuticals Ltd Performance

-

-

-

-


-

-

-

-

-

Remus Pharmaceuticals Ltd Fundamentals

1,146.29Cr

68.14

13.97

0.32

28.55

0.10%

139.28

i buttonClick here to know more about Fundamentals

Remus Pharmaceuticals Ltd Financials

Remus Pharmaceuticals Ltd Financialsright-arrow

Remus Pharmaceuticals Ltd Shareholding Pattern

Remus Pharmaceuticals Ltd Delivery and Volume

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a private compan

-

2015

REMUS

News and Events...

Similar Stocks

What's Trending

Remus Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Remus Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Remus Pharmaceuticals Ltd's share price is ₹1945.5 as of 2024-07-19.
Remus Pharmaceuticals Ltd's P/E ratio is 68.14 times as of 2024-07-19.
Remus Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 13.97, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Remus Pharmaceuticals Ltd's market capitalization is ₹1146.29 Cr as on 2024-07-19.
The current financial records of Remus Pharmaceuticals Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Remus Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹11.47, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Remus Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Remus Pharmaceuticals Ltd's 52-week high and low as of 2024-07-19 are ₹2048 and ₹1910, respectively.